Related Experiment Video
Updated: May 22, 2026

07:11
Isolation of Infiltrating Leukocytes from Mouse Skin Using Enzymatic Digest and Gradient Separation
Published on: January 25, 2016
Recent findings in mouse models for human atopic dermatitis.
Akane Tanaka1, Yosuke Amagai, Kumiko Oida
1Laboratory of Veterinary Molecular Pathology and Therapeutics, Division of Animal Life Science, Institute of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Experimental Animals
|April 26, 2012
Summary
Atopic dermatitis (AD) research benefits from the NC mouse model for studying allergic skin conditions. A new scratching behavior evaluation system aids in developing effective itch treatments for AD.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by persistent itch.
- Developing effective treatments for AD is challenging due to limited animal models that replicate human conditions.
- The NC mouse model has significantly advanced the study of AD pathogenesis and drug development.
Purpose of the Study:
- To review existing mouse models for atopic dermatitis (AD).
- To highlight the utility of the NC mouse model in AD research.
- To introduce a novel evaluation system for assessing scratching behavior in mice.
Main Methods:
- Review of existing literature on atopic dermatitis mouse models.
- Focus on the NC mouse model and its applications.
- Description of a new system for evaluating scratching behavior in mice.
Main Results:
- The NC mouse model is crucial for understanding AD pathogenesis and allergic skin abnormalities.
- Existing models have limitations in fully replicating AD complexity.
- A novel scratching behavior evaluation system has been developed.
Conclusions:
- The NC mouse model is invaluable for atopic dermatitis research.
- Further development of precise animal models and evaluation protocols is essential for effective AD itch treatment.
- The novel scratching behavior system can aid researchers in understanding AD pathogenesis and developing new therapies.
